Delivery Order SPE2DB22D3301-SPE2DB24FX8NN
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,431.92 for Ramelteon 8 mg tablets (30-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency awarded a $1,557.76 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ramelteon 8 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 23, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,856.49 to AmerisourceBergen Drug Corp for the supply of Ramelteon 8 mg tablets (30-count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $596.88 delivery order to Amerisourcebergen Drug Corporation for the provision of 30 Ramelteon 8 mg tablets. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will fulfill the order from its place of performance in Conshohocken, Pennsylvania under a firm fixed price arrangement. The order is funded by the Defense Logistics Agency and has a period of performance spanning August 21, 2023 through August 22, 2023. No set...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifteen thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of thirty boxes of eight milligram ramelteon tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from September 6 to September 7, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Ramelteon 8 mg tablets. The Delivery Order contract, valued at $6,303.62, has a completion date of December 29, 2023 and uses a Firm Fixed Price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RAMELTEON 8 MG TABLET UD 50S. The award has a ceiling value of $2,835.48 and an ultimate completion date of April 16, 2024. The contract type is Firm Fixed Price. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ramelteon 8 mg tablets, a prescription medication used to treat insomnia. The contract has a ceiling value of $2,364.11 and an ultimate completion date of September 13, 2024. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a...
- This federal contract award, SPE2DB22D3401|SPE2DB24FT4XB, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $1,148.04 delivery order is for the supply of RAMELTEON 8 MG TABLET 30S medication. The contract has a firm fixed price and an ultimate completion date of September 26, 2024. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50-count) with a contract ceiling value of $7,347.27. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The ultimate completion date is set for September 26, 2025, and the product will be delivered to AmerisourceBergen's location in Conshohocken,...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX8NNDelivery Order
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,511.45 contract is for the provision of 30-count tablets of the pharmaceutical drug Ramelteon 8 mg. The delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. The delivery order will be performed at Amerisourcebergen's corporate headquarters in Conshohocken, Pennsylvania, and has a completion date of January 12, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/11/24 |